Literature DB >> 8398686

Intention to treat--who should use ITT?

J A Lewis, D Machin.   

Abstract

Mesh：

Year:  1993        PMID： 8398686      PMCID： PMC1968589          DOI： 10.1038/bjc.1993.402

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  The analysis of failure time data in crossover studies.

Authors:  L A France; J A Lewis; R Kay
Journal:  Stat Med       Date:  1991-07       Impact factor: 2.373

2.  Statistical standards for protocols and protocol deviations.

Authors:  J A Lewis
Journal:  Recent Results Cancer Res       Date:  1988

3.  Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.

Authors:  M H Gail
Journal:  Cancer Treat Rep       Date:  1985-10

4.  A new approach to the analysis of clinical drug trials with withdrawals.

Authors:  A L Gould
Journal:  Biometrics       Date:  1980-12       Impact factor: 2.571

5.  The FDA's critique of the anturane reinfarction trial.

Authors:  R Temple; G W Pledger
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

6.  Correcting for the bias caused by drop-outs in hypertension trials.

Authors:  G D Murray; J G Findlay
Journal:  Stat Med       Date:  1988-09       Impact factor: 2.373

7.  Epanolol as a model for assessing patient preference in anti-anginal drug therapy.

Authors:  P Blake; J A Lewis
Journal:  J Clin Pharmacol       Date:  1992-01       Impact factor: 3.126

8.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
  9 in total
  41 in total

Review 1.  What is meant by intention to treat analysis? Survey of published randomised controlled trials.

Authors:  S Hollis; F Campbell
Journal:  BMJ       Date:  1999-09-11

2.  Bias.

Authors:  Miguel Delgado-Rodríguez; Javier Llorca
Journal:  J Epidemiol Community Health       Date:  2004-08       Impact factor: 3.710

3.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

4.  Standards of reporting of randomized controlled trials in general surgery: can we do better?

Authors:  Sabapathy P Balasubramanian; Martin Wiener; Zeiad Alshameeri; Ravindranath Tiruvoipati; Diana Elbourne; Malcolm W Reed
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 5.  Rectal cancer should not be resected laparoscopically: the rationale and the data.

Authors:  S K Abbas; S B Yelika; K You; J Mathai; R Essani; Z Krivokapić; R Bergamaschi
Journal:  Tech Coloproctol       Date:  2017-03-04       Impact factor: 3.781

6.  Vats Versus Axillary Minithoracotomy in the Management of the Second Episode of Spontaneous Pneumothorax: Cost-Benefit Analysis.

Authors:  Duilio Divisi; Gabriella Di Leonardo; Roberto Crisci
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

7.  Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology.

Authors:  K F Schulz; D A Grimes; D G Altman; R J Hayes
Journal:  BMJ       Date:  1996-03-23

8.  Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children.

Authors:  David Schnadower; Phillip I Tarr; T Charles Casper; Marc H Gorelick; J Michael Dean; Karen J O'Connell; Prashant Mahajan; Adam C Levine; Seema R Bhatt; Cindy G Roskind; Elizabeth C Powell; Alexander J Rogers; Cheryl Vance; Robert E Sapien; Cody S Olsen; Melissa Metheney; Viani P Dickey; Carla Hall-Moore; Stephen B Freedman
Journal:  N Engl J Med       Date:  2018-11-22       Impact factor: 91.245

9.  Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?

Authors:  Robert E Becker; Nigel H Greig
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

10.  Modified intention to treat reporting in randomised controlled trials: systematic review.

Authors:  Iosief Abraha; Alessandro Montedori
Journal:  BMJ       Date:  2010-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.